Hyloris Announces Commercial Partnership for Maxigesic® IV
Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia,...
Stay updated with breaking news from Kever Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Exclusive licensing and distribution agreement signed with Salus Pharmaceuticals in Lithuania, Estonia, Latvia, Croatia, Slovenia, Serbia, North Macedonia,...
Hyloris Announces Commercial Partnership for Maxigesic® IV in 9 European Countries - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ -- Collaboration for research and development is one of the key peptide therapeutics market trends that is expected to impact the industry...
After successfully launching the D-minePump, an infusion device designed to provide precise continuous subcutaneous drug delivery for Parkinson's patients, EVER Pharma developed an App to support the
Characterizing the presence of alpha-Synuclein and gliosis in patients with advanced Parkinson's.